KIF20A and breast carcinoma: GEPIA analysis disclosed that breast cancer patients have significantly higher expression of AURKA (4.0 vs. 1.5), AURKB (4 vs. 1), TTK (2.5 vs. 0.5), MELK (3.0 vs. 0.5), KIF20A (3.5 vs. 0.5) genes compared to healthy people.